iiinova — where your digital self keeps evolving

pstudenic.bsky.social @pstudenic.bsky.social · 24/08/2026

🔬 Difficult-to-treat When options run out, what works? 🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w #RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine

youtu.be

Flash Science in Rheumatology, Episode 6: Therapeutic approaches for difficult-to-treat RA

YouTube video by Division of Rheumatology - MUW Vienna

011

Reposted by @pstudenic.bsky.social

STRATA-FIT @strata-fit.bsky.social · 27/05/2026

Golnaz Shams has been selected for a poster presentation @eular.org Congress (3-6 June in London). The topic will be Clinical management strategies for difficult-to-treat rheumatoid arthritis. You can find the abstract and more information in the comments. @meduniwien.ac.at

101

Reposted by @pstudenic.bsky.social

Annals of the Rheumatic Diseases @ard.eular.org · 02/06/2026

🎉 Meet the brilliant ARD & ERO Guest Social Media Editors for #EULAR2026! 🚀 Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.

054

pstudenic.bsky.social @pstudenic.bsky.social · 29/09/2025

Die @oegrr erweitert ihre Kommunikationsbandbreite💢 #Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched! Spannend für #Patientinnen sowie Gesundheitspersonal

instagram.com

Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.

010

Reposted by @pstudenic.bsky.social

OEGRR @oegrr.bsky.social · 14/09/2025

Wir sind da! 🙂 🦴🩺 Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!

Check up our Homepage to know more about us and our projects!
https://rheumatologie.at

022

pstudenic.bsky.social @pstudenic.bsky.social · 02/07/2025

Super happy and proud about the publication of the first authored paper of my #PhD student Nasim Nakhost Lotfi in RMD Open 😊👏🎈 How reliable can we utilise different #PROMs in #apps when assessed in different frequencies? Have a look 👇 rmdopen.bmj.com/cgi/content/... #Rheum #ehealth #arthritis

020

pstudenic.bsky.social @pstudenic.bsky.social · 01/07/2025

@mdr-ra-project.bsky.social GA has brought together our consortium in the heat of #Verona These 2 days enabled clarity on setting the tracks to achieve our goals Endotypes of #D2T #RA Development of a clever #CDSS 😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social

040

pstudenic.bsky.social @pstudenic.bsky.social · 28/06/2025

2 weeks ago #EULAR2025 closed. A congress full of education and innovation spread over 4 days. Project Meetings (#Squeeze #Stratafit EULAR Meetings (qoc #bigdata #atrisk) 2 lectures on #AIforIA & #PRPinvolvement together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks

020

Reposted by @pstudenic.bsky.social

teresaoton.bsky.social @teresaoton.bsky.social · 12/06/2025

Christina Wettengl delivered an excellent oral presentation on the #ContextualAnalysis for the Care Model development in Switzerland for @squeezeproject.bsky.social #EULAR2025

061

pstudenic.bsky.social @pstudenic.bsky.social · 14/06/2025

#EULAR2025 also offered the possibilty to come together for scientific project meetings. The @squeezeproject.bsky.social Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas

093

pstudenic.bsky.social @pstudenic.bsky.social · 14/06/2025

One of the most crucial sessions for research in #rheumatology just started: How to involve patients in your #research 💢Get your insights in #collaborativeresearch now 🤝 #EULAR2025 #PRP

091

Reposted by @pstudenic.bsky.social

Dr Simon Stones @simonrstones.bsky.social · 13/06/2025

Fantastic to see Sladjana, a STRATA-FIT patient research partner, presenting about the project and the evaluation of PRP involvement - partnership, communication, and support are critical #eular2025

052

Reposted by @pstudenic.bsky.social

SQUEEZE project @squeezeproject.bsky.social · 12/06/2025

Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV

141

pstudenic.bsky.social @pstudenic.bsky.social · 11/06/2025

Very intense phenotyping of patients with RA in Remission double checked with #US comparing people tapering & stopping DMARD treatment with those continuing for the occurrence of #flare. #spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025

030

pstudenic.bsky.social @pstudenic.bsky.social · 11/06/2025

Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348 @squeezeproject.bsky.social #EULAR2025

071

Reposted by @pstudenic.bsky.social

The Lancet Rheumatology @thelancetrheum.bsky.social · 17/04/2025

ICYMI, the inspiration for our April cover—Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial bit.ly/3GpCl9X Plus linked Comment bit.ly/4ivhVKo #Medsky #Rheumsky

031

pstudenic.bsky.social @pstudenic.bsky.social · 16/04/2025

Thank you @gregorbond.bsky.social for enriching the frame of biomarkers in the field of #rheumatoidarthritis. #TTV as biomarker of immunosuppression has for sure different facets. I always enjoy the #interdisciplinary exchange

040

pstudenic.bsky.social @pstudenic.bsky.social · 05/04/2025

The last two days were dedicated to intense discussions, phrasing Update recommendations for large vessel #vasculitis - #LVV - Combining expertise from 15 countries Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti

032

pstudenic.bsky.social @pstudenic.bsky.social · 22/03/2025

#Digitalrheumatology days update #RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety CBT was integrated into a 90 days program delivered via a smartphone app. Promising results presented by @johannesknitza 👇

042

pstudenic.bsky.social @pstudenic.bsky.social · 22/03/2025

These days the #Digital #Rheumatology days are on again in #Berlin. #7th Edition An interdisciplinary audience from 19 countries come together. 🌐 I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth New insights and productive exchange 💢

062

Reposted by @pstudenic.bsky.social

European Commission @ec.europa.eu · 13/03/2025

Say hello to Europe's six new new AI Factories: 🇦🇹 AI:AT 🇧🇬 BRAIN++ 🇫🇷 AI2F 🇩🇪 JAIF 🇵🇱 PIAST 🇸🇮 SLAIF These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓ europa.eu/!F6KGPG

A map of Europe highlighting the locations of six new AI factories established by the European Union. The factories are marked with icons and are distributed as follows: Selected in December 2024 (blue markers): MIMER AI Factory at the University of Linköping, Sweden, ITALIA AI Factory at CINECA, Italy; BSC AI Factory at the Barcelona Supercomputing Centre, Spain; HammerHAI at the University of Stuttgart, Germany; Meluxina-AI at the LuxPriovide, Luxembourg; Pharos at GRNET, Greece. Selected in March 2025 (purple markers): AI2F in Bruyères-le-Châtel, France; JAIF in Jülich, Germany, PIAST AIF in Poznań, Poland; AIAAT in Vienna, Austria, SLAIF in Maribor, Slovenia; BRAIN++ in Sofia, Bulgaria. The map uses shades of purple to indicate the countries where the factories are located and includes EU branding at the top.

1228260

Reposted by @pstudenic.bsky.social

ACR Journals @acr-journals.bsky.social · 11/03/2025

Cross-sectional study in the VA rheumatoid arthritis registry identified 8 peripheral blood biomarkers that could improve RA-interstitial lung disease risk stratification beyond clinical risk factors In A&R acrjournals.onlinelibrary.wiley.com/doi/10.1002/... #Medsky #Pulmsky

Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Graphical abstract created with BioRender

022

pstudenic.bsky.social @pstudenic.bsky.social · 08/03/2025

International women's day 8th of March developments in steps Studying #medicine for women in Vienna was possible only since the start of the 20th century Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades

010

Reposted by @pstudenic.bsky.social

ACR Journals @acr-journals.bsky.social · 21/02/2025

Bayesian meta-analysis of RCTs compared efficacy and safety of JAK inhibitors vs bDMARDs for nonsystemic forms of juvenile idiopathic arthritis. Results showed no significant difference in efficacy and safety outcomes among the treatment options In ACROR doi.org/10.1002/acr2... #Medsky

Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. Graphical abstract created with BioRender

022

pstudenic.bsky.social @pstudenic.bsky.social · 17/02/2025

FIRST #EULAR Quality of Care webinar "Diagnosis and Treatment of Giant Cell Arteritis"! Wednesday, 19 February 2025, 17:00 -18:00 CET This one touches on the products of EULAR aiming to aid #rheumatologists in different aspects around #GCA! Register here👉 lnkd.in/dct7mYAC

010